GOCD Tool for End of Life Care
(ASKMEGOC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the GOCD Tool, created to facilitate clear conversations between doctors and patients about end-of-life care. It aims to ensure that patients' treatment preferences are identified and respected by comparing the new tool to usual care practices. The trial seeks hospitalized patients aged 80 or older who have previously discussed life-sustaining treatments and can communicate in English or have a translator. As an unphased trial, it offers patients the chance to contribute to enhancing communication about end-of-life care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on end-of-life care discussions rather than medication changes.
What prior data suggests that this tool is safe for end-of-life care discussions?
Research has shown that the GOCD Tool has been tested with small groups of hospital patients, who found it both acceptable and helpful. Although specific safety data for the GOCD Tool itself is lacking, similar tools used for discussing care goals have not raised any safety concerns.
Because the GOCD Tool is neither a medication nor a procedure that involves entering the body, it is generally considered safe for use. It facilitates discussions between doctors and patients about preferences for end-of-life care. No reports of physical side effects or negative events have been directly linked to its use.12345Why are researchers excited about this trial?
Researchers are excited about the GOCD Tool for end-of-life care because it introduces a web-based shared-decision making software for facilitating goals-of-care discussions in intensive care units. Unlike the traditional approach where physicians conduct these important conversations directly with patients, the GOCD Tool provides a structured, digital platform to support decision-making. This method aims to enhance communication, ensure patient preferences are clearly understood and respected, and potentially improve overall patient satisfaction with their care during such a critical time.
What evidence suggests that the GOCD Tool is effective for end-of-life care?
Research shows that discussing end-of-life care aligns patient preferences with the treatments they receive, reducing unwanted treatments and suffering. In this trial, participants will either use the GOCD Tool, a web-based shared-decision-making software, or engage in usual care discussions with an attending physician. Studies have found that tools like the GOCD Tool help ensure patient wishes are recorded and followed. Both patients and healthcare providers find these tools useful and acceptable. Early feedback from a small group suggests the GOCD Tool effectively makes these discussions more meaningful and aligned with patient desires.26789
Who Is on the Research Team?
Giulio Didiodato, MD
Principal Investigator
Royal Victoria Regional Health Centre
Chris Martin, MD
Principal Investigator
Royal Victoria Regional Health Centre
Doug Austgarden, MD
Principal Investigator
Royal Victoria Regional Health Centre
Are You a Good Fit for This Trial?
This trial is for hospitalized patients who are at least 80 years old, facing serious medical or surgical conditions, and can make decisions for themselves or have someone to do it for them. They must be able to communicate in English or have a translator available.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Facilitated Goals of Care Discussions (GOCDs) using a web-based shared-decision making tool
Follow-up
Participants are monitored for outcomes such as ICU days, ventilator use, and dialysis days up to 12 months post-admission
Evaluation
Evaluation of patient satisfaction and quality of communication regarding the GOCD tool
What Are the Treatments Tested in This Trial?
Interventions
- GOCD Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
Royal Victoria Hospital, Canada
Lead Sponsor
Alectra
Collaborator
Royal Victoria Foundation
Collaborator
Royal Victoria Regional Health Centre
Collaborator